Triludan (terfenadine)
The effectiveness of Triludan (terfenadine) against bronchial asthma has not been established, since the method of evaluation was not scientific. Above all, patients were not informed of serious side effects such as death, to avoid any risks.
Therefore, we issued 6 written requests to MHLW and Hoechst Marion Roussel, from 1997 to 2000.
After 3 years and 3 months of repeated requests, the sale of Triludan came to an end.
Topics
- YAKUGAI Ombudsperson
- Tie-up Group
No Related Information
